Department of Biomedical Sciences, Section of Neuropsychopharmacology, University of Cagliari, Cagliari, Italy.
National Institute of Neuroscience (INN), University of Cagliari, Cagliari, Italy.
Addict Biol. 2018 Nov;23(6):1207-1222. doi: 10.1111/adb.12642. Epub 2018 Jun 27.
Loren (Larry) H. Parsons passed away at the age of 51. In spite of his premature departure, Larry much contributed to the drug abuse field. Since his graduate studies for the Ph.D. in Chemistry in J.B. Justice lab, microdialysis is the tread that links Larry's research topics, namely, the role of dopamine (DA), serotonin (5-HT), gamma-aminobutyric acid (GABA), glutamate and endocannabinoids (eCBs) in drug reinforcement and dependence. Larry was the first to show that abstinence from chronic cocaine reduces extracellular DA in the NAc, consistent with the so called 'dopamine depletion hypothesis' of cocaine addiction. Another Larry's major contributions are the studies on 5-HT and 5-HT receptors' role in cocaine stimulant actions, which resulted in the identification of 5-HT1B receptors as a critical substrate of cocaine reinforcement. By applying mass spectrometry to eCBs analysis in brain dialysates, Larry's lab showed that ethanol, heroin, nicotine and cocaine differentially affect anandamide and 2-arachidonoylglicerol overflow in the NAc shell, a critical site of drugs of abuse DA stimulant actions. Larry also applied microdialysis to study GABA and glutamate's role in ethanol dependence and heroin reinforcement, providing in vivo evidence for a sensitization of corticotropin-releasing factor-dependent release of GABA in the central amygdala in withdrawal from chronic ethanol and for a reduction of GABA transmission in the ventral pallidum in heroin but not cocaine intravenous self-administration. Larry showed the wide possibilities of microdialysis as a general purpose methodology for monitoring neurotransmitters and neuromodulators in the brain extracellular compartment. From this viewpoint, he stands as the best advocate for microdialysis.
洛伦(拉里)·H·帕森斯(Loren (Larry) H. Parsons)去世,享年 51 岁。尽管他英年早逝,但拉里为药物滥用领域做出了巨大贡献。自他在 J.B. Justice 实验室攻读化学博士学位以来,微透析一直是联系拉里研究课题的线索,这些课题包括多巴胺(DA)、5-羟色胺(5-HT)、γ-氨基丁酸(GABA)、谷氨酸和内源性大麻素(eCBs)在药物强化和依赖中的作用。拉里是第一个证明慢性可卡因戒断会减少 NAc 中细胞外的 DA,这与可卡因成瘾的所谓“多巴胺耗竭假说”一致。拉里的另一项重大贡献是关于 5-HT 和 5-HT 受体在可卡因兴奋剂作用中的作用的研究,这导致了 5-HT1B 受体被确定为可卡因强化的关键底物。通过将质谱法应用于脑透析液中的 eCBs 分析,拉里的实验室表明,乙醇、海洛因、尼古丁和可卡因会对 NAc 壳中的大麻素和 2-花生四烯酰甘油的溢出产生不同的影响,这是滥用药物 DA 兴奋剂作用的关键部位。拉里还应用微透析研究 GABA 和谷氨酸在乙醇依赖和海洛因强化中的作用,为慢性乙醇戒断后中脑杏仁核中促肾上腺皮质释放因子依赖性 GABA 释放的敏化以及海洛因而不是可卡因静脉内自我给药中腹侧苍白球中 GABA 传递减少提供了体内证据。拉里展示了微透析作为监测大脑细胞外间隙中神经递质和神经调质的通用方法的广泛可能性。从这个角度来看,他是微透析的最佳倡导者。